Transcriptome complexity in intravascular NK/T-cell lymphoma.

Area of Science:

• Hematology
• Genomics
• Oncology

Background:

• Intravascular NK/T-cell lymphoma (IVNKTCL) is a rare malignancy characterized by endothelial-lined vascular spaces filled with lymphoma cells.
• Epstein-Barr virus infection and somatic mutations in epigenetic regulators are associated with IVNKTCL.
• The transcriptomic landscape of IVNKTCL remains incompletely understood.

Purpose of the Study:

• To elucidate the transcriptomic complexity of Intravascular NK/T-cell lymphoma (IVNKTCL).
• To identify alternative splicing events and mutations in splicing factors contributing to IVNKTCL pathogenesis.

Main Methods:

• RNA sequencing (RNA-seq) was performed on 25 intravascular lymphoma cases.
• Whole exome sequencing (WES) was utilized to analyze mutations in splicing factors.
• Transcriptomic abnormalities and splicing factor mutations were analyzed.

Main Results:

• RNA-seq revealed 28,941 alternative splicing events, including tumor-specific alterations in oncogenes (e.g., HRAS, MDM2, VEGFA).
• Approximately 12% of RNA-seq reads mapped to intronic or intergenic regions, suggesting non-exonic expression.
• WES identified mutations or copy number losses in 15 splicing regulator genes (e.g., SF3B5, SRSF12, TNPO3).

Conclusions:

• Aberrant splicing and non-exonic expression contribute to IVNKTCL.
• Complex regulatory loops involving splicing defects and epigenetic alterations may drive IVNKTCL.
• Further research into these mechanisms could reveal therapeutic targets for IVNKTCL.